Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 16.15% is 97% above its 5-year average of 8.18%, near the high end of its 5-year range (4.88%–16.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.69% above its 12-month average of 13.06%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.15%.
DEBT TO ASSETS RATIO
16.15%
DEBT TO ASSETS RATIO AVG TTM
13.06%
DEBT TO ASSETS RATIO AVG 3Y
9.34%
DEBT TO ASSETS RATIO AVG 5Y
8.18%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+23.69%
CURRENT VS 3Y AVG
+72.95%
CURRENT VS 5Y AVG
+97.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 843 covered companies
CURRENT VS SECTOR MEDIAN
+17842.76%
vs the sector median at left
Alector, Inc.
Market Cap
$204.12M
Debt to Assets Ratio
16.15%
TTM Avg
13.06%
3Y Avg
9.34%
5Y Avg
8.18%
Market Cap
$205.37M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$205.99M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$206.91M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$208.31M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $204.12M | 16.15% | 13.06% | 9.34% | 8.18% |
| Sionna Therapeutics, Inc. (SION)vs › | $205.37M | 0.03% | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $205.74M | 0.24% | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $205.99M | 0.20% | N/A | N/A | N/A |
| Entrada Therapeutics, Inc. (TRDA)vs › | $206.91M | 0.16% | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $200.41M | 0.49% | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
| Surrozen, Inc. (SRZN)vs › | $198.15M | 0.05% | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $210.85M | 0.02% | N/A | N/A | N/A |
| Prelude Therapeutics Incorporated (PRLD)vs › | $211.35M | 0.09% | N/A | N/A | N/A |
Debt/Assets
16.1%
Debt/Equity
N/A
Current Ratio
5.26
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 16.15% |
| 2026-03-31 | 14.40% |
| 2025-12-31 | 12.36% |
| 2025-09-30 | 11.30% |
| 2025-06-30 | 11.08% |
| 2025-03-31 | 10.05% |
| 2024-12-31 | 9.08% |
| 2024-09-30 | 6.71% |
| 2024-06-30 | 6.33% |
| 2024-03-31 | 5.91% |
| 2023-12-31 | 6.26% |
| 2023-09-30 | 5.98% |
| 2023-06-30 | 5.78% |
| 2023-03-31 | 5.64% |
| 2022-12-31 | 5.50% |
| 2022-09-30 | 5.31% |
| 2022-06-30 | 5.12% |
| 2022-03-31 | 4.88% |
| 2021-12-31 | 5.84% |
| 2021-09-30 | 5.69% |
| 2021-06-30 | 12.49% |
| 2021-03-31 | 11.47% |
| 2020-12-31 | 10.50% |
| 2020-09-30 | 8.65% |
| 2020-06-30 | 8.17% |
| 2020-03-31 | 7.66% |
| 2019-12-31 | 11.39% |
| 2019-09-30 | 10.70% |
| 2019-06-30 | 10.04% |
| 2019-03-31 | 9.64% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2017-12-31 | 0.00% |
